Cardiac Manifestations in Children with Inborn Errors of Metabolism

Kyriaki Papadopoulou-Legbelou1, Maria Gogou, Athanasios Evangeliou

  • 1From 4th Department of Pediatrics, School of Medicine, Aristotle University of Thessaloniki, Papageorgiou General Hospital, Thessaloniki, Greece. Correspondence to: Dr Maria Gogou, Dimitriou Nika 44, 60 100, Katerini, Greece. mariaangogou@gmail.com.

Indian Pediatrics
|September 12, 2017
PubMed

Insights

Cardiac involvement is common in inborn errors of metabolism (IEMs) in children. Cardiomyopathy is frequent, while rhythm and valve issues vary by IEM type, necessitating systematic cardiac screening.

Area of Science:

  • Pediatric Cardiology
  • Metabolic Disorders
  • Genetics

Background:

  • Cardiac involvement is a recognized, yet understudied, feature of inborn errors of metabolism (IEMs).
  • Understanding the spectrum of cardiac manifestations in pediatric IEMs is crucial for timely diagnosis and management.

Purpose of the Study:

  • To systematically review cardiac manifestations of inborn errors of metabolism in childhood.
  • To identify patterns of cardiac involvement across different metabolic disorder categories.

Main Methods:

  • A comprehensive PubMed database search was conducted by two independent reviewers.
  • Studies published within the last 20 years were included, irrespective of study design.
  • Case series and reports were identified to gather data on cardiac findings in pediatric IEMs.

Main Results:

  • Cardiomyopathy is the most prevalent cardiac disorder across various metabolic defects.
  • Heart rhythm abnormalities are common in mitochondrial disorders and acidemias.
  • Valvular dysfunction is a key feature of storage disorders, often presenting later.

Conclusions:

  • Cardiac involvement in mitochondrial disorders, congenital disorders of glycosylation, and acidemias often appears early.
  • In storage disorders, cardiac issues typically manifest later, except in Pompe disease.
  • Systematic cardiac screening is essential for children diagnosed with inborn errors of metabolism due to diverse cardiac presentations.
Abstract

Related Concept Videos

Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
944
Mechanism of Cardiac Arrhythmias01:28

Mechanism of Cardiac Arrhythmias

Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
2.4K
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
550
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
675
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
452
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
634